Validation of the Utah Photophobia Symptom Impact Scale (version 2) as a headache‐specific photophobia assessment tool
暂无分享,去创建一个
Morgan M. Millar | A. Presson | K. Digre | K. Brennan | B. Katz | M. Cortez | Chong Zhang | Alexander M Knudson | Cecilia Martindale | J. Kean
[1] K. Digre,et al. The Unmet Challenge of Diagnosing and Treating Photophobia , 2022, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[2] M. Ashina,et al. Migraine and light: A narrative review , 2022, Headache.
[3] K. Hirata,et al. Investigating the relationships between the burden of multiple sensory hypersensitivity symptoms and headache-related disability in patents with migraine , 2021, The Journal of Headache and Pain.
[4] H. Diener,et al. Efficacy and safety of fremanezumab in patients with episodic and chronic migraine with documented inadequate response to 2 to 4 classes of migraine preventive medications over 6 months of treatment in the phase 3b FOCUS study , 2021, The Journal of Headache and Pain.
[5] C. Sciarretta,et al. Photophobia and allodynia in persistent post-traumatic headache are associated with higher disease burden , 2021, Cephalalgia : an international journal of headache.
[6] F. Dach,et al. Interictal Photophobia and Phonophobia Are Related to the Presence of Aura and High Frequency of Attacks in Patients with Migraine , 2021, Applied Sciences.
[7] Carrie R. Houts,et al. Systematic review of outcomes and endpoints in acute migraine clinical trials , 2021, Headache.
[8] Carrie R. Houts,et al. Systematic review of outcomes and endpoints in preventive migraine clinical trials , 2021, Headache.
[9] R. Lipton,et al. Most Bothersome Symptom in Persons With Migraine: Results From the Migraine in America Symptoms and Treatment (MAST) Study , 2019, Headache.
[10] Paul A. Harris,et al. The REDCap consortium: Building an international community of software platform partners , 2019, J. Biomed. Informatics.
[11] K. Digre,et al. Validation of a photophobia symptom impact scale , 2019, Cephalalgia : an international journal of headache.
[12] Theodoros A. Kyriazos,et al. Applied Psychometrics: Sample Size and Sample Power Considerations in Factor Analysis (EFA, CFA) and SEM in General , 2018 .
[13] M. Ferrari,et al. Quantifying visual allodynia across migraine subtypes: the Leiden Visual Sensitivity Scale , 2018, Pain.
[14] D. Copenhagen,et al. Current understanding of photophobia, visual networks and headaches , 2018, Cephalalgia : an international journal of headache.
[15] Sera L. Young,et al. Best Practices for Developing and Validating Scales for Health, Social, and Behavioral Research: A Primer , 2018, Front. Public Health.
[16] K. C. Brennan,et al. A Systems Neuroscience Approach to Migraine , 2018, Neuron.
[17] Granville James Matheson,et al. We need to talk about reliability: making better use of test-retest studies for study design and interpretation , 2018, bioRxiv.
[18] Hunter Gehlbach,et al. The Survey Checklist (Manifesto). , 2017, Academic medicine : journal of the Association of American Medical Colleges.
[19] M. Hallett,et al. Photophobia in neurologic disorders , 2017, Translational Neurodegeneration.
[20] K. Digre,et al. Altered pupillary light response scales with disease severity in migrainous photophobia , 2017, Cephalalgia : an international journal of headache.
[21] H. Rossi,et al. Photophobia in Primary Headaches , 2015, Headache.
[22] M. Kosinski,et al. Validating Migraine‐Specific Quality of Life Questionnaire v2.1 in Episodic and Chronic Migraine , 2012, Headache.
[23] K. C. Brennan,et al. Shedding light on photophobia. , 2012, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[24] Min Yang,et al. Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine , 2011, Cephalalgia : an international journal of headache.
[25] A. Farmer,et al. Diagnosing migraine in research and clinical settings: The validation of the Structured Migraine Interview (SMI) , 2010, BMC neurology.
[26] Pennifer Erickson,et al. Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[27] C. Chung,et al. Usefulness of a Photophobia Questionnaire in Patients With Migraine , 2009, Cephalalgia : an international journal of headache.
[28] A. Fagiolini,et al. Photosensitivity in panic disorder , 2009, Depression and anxiety.
[29] K. Digre,et al. The evaluation of light sensitivity in benign essential blepharospasm. , 2006, American journal of ophthalmology.
[30] B. Löwe,et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. , 2006, Archives of internal medicine.
[31] A. Dowson,et al. A six-item short-form survey for measuring headache impact: The HIT-6™ , 2003, Quality of Life Research.
[32] R. Spitzer,et al. The PHQ-9 , 2001, Journal of General Internal Medicine.
[33] R. Lipton,et al. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability , 2001, Neurology.
[34] R. Lipton,et al. Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers , 2000, Pain.
[35] Jon A. Krosnick,et al. Designing Rating Scales for Effective Measurement in Surveys , 1997 .
[36] P D Drummond,et al. A Quantitative Assessment of Photophobia in Migraine and Tension Headache , 1986, Headache.
[37] G. Masters. A rasch model for partial credit scoring , 1982 .
[38] M. Arnold. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition , 2018, Cephalalgia : an international journal of headache.
[39] R. Spitzer,et al. The PHQ-9: validity of a brief depression severity measure. , 2001, Journal of general internal medicine.